Investor Presentation evening for Venn Life Sciences 22nd Sept

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, will be reporting its interim results for the six months ended 30 June 2015 on Tuesday 22 September 2015.

 

Analyst presentation

Tony Richardson, Chief Executive Officer and Jonathan Hartshorn, Chief Financial Officer will be hosting an analyst briefing on the day of results, Tuesday 22 September 2015, at 9.30am at Walbrook PR, 4 Lombard Street, London, EC3V 9HD.

 

Investor results presentation

A briefing for all investors will take place on Tuesday 22 September 2015 at Rocket, 6 Adams Court, Old Broad Street, London, EC4N 1DX from 5.00pm for a 5.15pm start, and will be followed by drinks and canapés.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    DirectorsTalk

    More articles like this